Host response transcriptional profiling reveals extracellular components and ABC (ATP-binding cassette) transporters gene enrichment in typhoid fever-infected Nigerian children

BMC Infectious Diseases

Volumn 11, Issue , 2011, Pages

  Khoo, Sok K ^a   Petillo, David ^a   Parida, Mrutyunjaya ^a   Tan, Aik C ^b   Resau, James H ^a   Obaro, Stephen K ^c  

^a VAN ANDEL RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTIBIOTIC AGENT; LIPOCALIN; PEPTIDE; ABC TRANSPORTER;

ABCA7 GENE; ABCD4 GENE; ACUTE DISEASE; ADOLESCENT; ARTICLE; ATP BINDING CASSETTE TRANSPORTER GENE; CHILD; CONTROLLED STUDY; CONVALESCENCE; DOWN REGULATION; ENZYME ACTIVITY; ETHNIC GROUP; FEMALE; GENE; GENE CLUSTER; GENE CONTROL; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFANT; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MICROBIAL ACTIVITY; NIGERIAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PREDICTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALMONELLA TYPHI; TYPHOID FEVER; BIOSYNTHESIS; CELL CULTURE; IMMUNOLOGY; LEUKOCYTE; NIGERIA; PATHOGENICITY; PATHOLOGY; PRESCHOOL CHILD; REAL TIME POLYMERASE CHAIN REACTION;

ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFANT; LEUKOCYTES; MALE; MICROARRAY ANALYSIS; NIGERIA; REAL-TIME POLYMERASE CHAIN REACTION; SALMONELLA TYPHI; TYPHOID FEVER;

EID: 80052657824     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-11-241     Document Type: Article

References (45)

1. Bhutta ZA, Threlfall J. Addressing the global disease burden of typhoid fever. JAMA 2009, 302(8):898-899. 10.1001/jama.2009.1259, 19706867.
2. WHO Background document: the diagnosis, prevention and treatment of typhoid fever. WHO 2003, 19-23. WHO.
3. Feasey NA, Archer BN, Heyderman RS, Sooka A, Dennis B, Gordon MA, Keddy KH. Emerg Infect Dis 16(9):1448-1451.
4. Bhutta ZA. Impact of age and drug resistance on mortality in typhoid fever. Arch Dis Child 1996, 75(3):214-217. 10.1136/adc.75.3.214, 1511710, 8976660.
5. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ. Typhoid fever. N Engl J Med 2002, 347(22):1770-1782. 10.1056/NEJMra020201, 12456854.
6. Dutta S, Sur D, Manna B, Sen B, Deb AK, Deen JL, Wain J, Von Seidlein L, Ochiai L, Clemens JD, et al. Evaluation of new-generation serologic tests for the diagnosis of typhoid fever: data from a community-based surveillance in Calcutta, India. Diagn Microbiol Infect Dis 2006, 56(4):359-365. 10.1016/j.diagmicrobio.2006.06.024, 16938421.
7. Mweu E, English M. Typhoid fever in children in Africa. Trop Med Int Health 2008, 13(4):532-540. 10.1111/j.1365-3156.2008.02031.x, 2660514, 18312473.
8. Cooke FJ, Wain J. The emergence of antibiotic resistance in typhoid fever. Travel Med Infect Dis 2004, 2(2):67-74. 10.1016/j.tmaid.2004.04.005, 17291961.
9. Klugman KP, Koornhof HJ, Robbins JB, Le Cam NN. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996, 14(5):435-438. 10.1016/0264-410X(95)00186-5, 8735556.
10. Whitaker JA, Franco-Paredes C, del Rio C, Edupuganti S. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas. J Travel Med 2009, 16(1):46-52. 10.1111/j.1708-8305.2008.00273.x, 19192128.
11. Loke P, Hammond SN, Leung JM, Kim CC, Batra S, Rocha C, Balmaseda A, Harris E. Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism. PLoS Negl Trop Dis 4(6):e710.
12. Ardura MI, Banchereau R, Mejias A, Di Pucchio T, Glaser C, Allantaz F, Pascual V, Banchereau J, Chaussabel D, Ramilo O. Enhanced monocyte response and decreased central memory T cells in children with invasive Staphylococcus aureus infections. PLoS One 2009, 4(5):e5446. 10.1371/journal.pone.0005446, 2676512, 19424507.
13. Andersson H, Hartmanova B, Back E, Eliasson H, Landfors M, Naslund L, Ryden P, Sjostedt A. Transcriptional profiling of the peripheral blood response during tularemia. Genes Immun 2006, 7(6):503-513. 10.1038/sj.gene.6364321, 16826236.
14. Kim HS, Choi EH, Khan J, Roilides E, Francesconi A, Kasai M, Sein T, Schaufele RL, Sakurai K, Son CG, et al. Expression of genes encoding innate host defense molecules in normal human monocytes in response to Candida albicans. Infect Immun 2005, 73(6):3714-3724. 10.1128/IAI.73.6.3714-3724.2005, 1111842, 15908401.
15. Griffiths MJ, Shafi MJ, Popper SJ, Hemingway CA, Kortok MM, Wathen A, Rockett KA, Mott R, Levin M, Newton CR, et al. Genomewide analysis of the host response to malaria in Kenyan children. J Infect Dis 2005, 191(10):1599-1611. 10.1086/429297, 15838786.
16. Wittwer M, Grandgirard D, Rohrbach J, Leib SL. Tracking the transcriptional host response from the acute to the regenerative phase of experimental pneumococcal meningitis. BMC Infect Dis 10:176.
17. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
18. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.
19. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
20. Obaro S, Lawson L, Essen U, Ibrahim K, Brooks K, Otuneye A, Shetima D, Ahmed P, Ajose T, Olugbile M, et al. Community acquired bacteremia in young children from central Nigeria- a pilot study. BMC infectious diseases 2011, 11:137. 10.1186/1471-2334-11-137, 3111365, 21595963.
21. Iwasaki A, Medzhitov R. Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5(10):987-995. 10.1038/ni1112, 15454922.
22. Franchi L, Park JH, Shaw MH, Marina-Garcia N, Chen G, Kim YG, Nunez G. Intracellular NOD-like receptors in innate immunity, infection and disease. Cell Microbiol 2008, 10(1):1-8.
23. Hoebe K, Janssen E, Beutler B. The interface between innate and adaptive immunity. Nat Immunol 2004, 5(10):971-974. 10.1038/ni1004-971, 15454919.
24. Flower DR. Multiple molecular recognition properties of the lipocalin protein family. J Mol Recognit 1995, 8(3):185-195. 10.1002/jmr.300080304, 8573354.
25. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004, 432(7019):917-921. 10.1038/nature03104, 15531878.
26. Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and iron-sequestering effects in response to bacterial enterobactin. PLoS Pathog 2009, 5(10):e1000622. 10.1371/journal.ppat.1000622, 2757716, 19834550.
27. Aujla SJ, Chan YR, Zheng M, Fei M, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, et al. IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 2008, 14(3):275-281. 10.1038/nm1710, 2901867, 18264110.
28. Hiroshima Y, Bando M, Kataoka M, Inagaki Y, Herzberg MC, Ross KF, Hosoi K, Nagata T, Kido JI. Regulation of antimicrobial peptide expression in human gingival keratinocytes by interleukin-1alpha. Arch Oral Biol
29. Conti HR, Shen F, Nayyar N, Stocum E, Sun JN, Lindemann MJ, Ho AW, Hai JH, Yu JJ, Jung JW, et al. Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 2009, 206(2):299-311. 10.1084/jem.20081463, 2646568, 19204111.
30. Raffatellu M, George MD, Akiyama Y, Hornsby MJ, Nuccio SP, Paixao TA, Butler BP, Chu H, Santos RL, Berger T, et al. Lipocalin-2 resistance confers an advantage to Salmonella enterica serotype Typhimurium for growth and survival in the inflamed intestine. Cell Host Microbe 2009, 5(5):476-486. 10.1016/j.chom.2009.03.011, 2768556, 19454351.
31. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, Raymond KN, Wanner BL, Strong RK, Walsh CT, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA 2006, 103(44):16502-16507. 10.1073/pnas.0604636103, 1637611, 17060628.
32. Ghosh S, Chakraborty K, Nagaraja T, Basak S, Koley H, Dutta S, Mitra U, Das S. An adhesion protein of Salmonella enterica serovar Typhi is required for pathogenesis and potential target for vaccine development. Proc Natl Acad Sci USA 108(8):3348-3353.
33. Tsolis RM, Young GM, Solnick JV, Baumler AJ. From bench to bedside: stealth of enteroinvasive pathogens. Nat Rev Microbiol 2008, 6(12):883-892. 10.1038/nrmicro2012, 18955984.
34. Goncharova IA, Beloborodova EV, Freidin MB, Beloborodova EI, pyzurev VP. [Association of immune system gene polymorphisms with quantitative features which are pathogenetically important in chronic viral hepatitis]. Mol Biol (Mosk) 2008, 42(2):242-246.
35. Xia R, Tang Y, Huang Y, Yao D, Zhou Y, Chen B, Chen Y, Chen S, Deng A, Zhong R. TNFSF9 expression in primary biliary cirrhosis and its clinical significance. Cytokine 50(3):311-316.
36. Vanhollebeke B, De Muylder G, Nielsen MJ, Pays A, Tebabi P, Dieu M, Raes M, Moestrup SK, Pays E. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 2008, 320(5876):677-681. 10.1126/science.1156296, 18451305.
37. Thomson R, Samanovic M, Raper J. Activity of trypanosome lytic factor: a novel component of innate immunity. Future Microbiol 2009, 4(7):789-796. 10.2217/fmb.09.57, 2777647, 19722834.
38. Thompson LJ, Dunstan SJ, Dolecek C, Perkins T, House D, Dougan G, Nguyen TH, Tran TP, Doan CD, Le TP, et al. Transcriptional response in the peripheral blood of patients infected with Salmonella enterica serovar Typhi. Proc Natl Acad Sci USA 2009, 106(52):22433-22438. 10.1073/pnas.0912386106, 2792164, 20018727.
39. Keuter M, Dharmana E, Gasem MH, van der Ven-Jongekrijg J, Djokomoeljanto R, Dolmans WM, Demacker P, Sauerwein R, Gallati H, van der Meer JW. Patterns of proinflammatory cytokines and inhibitors during typhoid fever. J Infect Dis 1994, 169(6):1306-1311. 10.1093/infdis/169.6.1306, 8195608.
40. Raffatellu M, Santos RL, Chessa D, Wilson RP, Winter SE, Rossetti CA, Lawhon SD, Chu H, Lau T, Bevins CL, et al. The capsule encoding the viaB locus reduces interleukin-17 expression and mucosal innate responses in the bovine intestinal mucosa during infection with Salmonella enterica serotype Typhi. Infect Immun 2007, 75(9):4342-4350. 10.1128/IAI.01571-06, 1951168, 17591794.
41. Wilson RP, Raffatellu M, Chessa D, Winter SE, Tukel C, Baumler AJ. The Vi-capsule prevents Toll-like receptor 4 recognition of Salmonella. Cell Microbiol 2008, 10(4):876-890. 10.1111/j.1462-5822.2007.01090.x, 18034866.
42. Wijnholds J, Mol CA, van Deemter L, de Haas M, Scheffer GL, Baas F, Beijnen JH, Scheper RJ, Hatse S, De Clercq E, et al. Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs. Proc Natl Acad Sci USA 2000, 97(13):7476-7481. 10.1073/pnas.120159197, 16570, 10840050.
43. Oguri T, Isobe T, Suzuki T, Nishio K, Fujiwara Y, Katoh O, Yamakido M. Increased expression of the MRP5 gene is associated with exposure to platinum drugs in lung cancer. Int J Cancer 2000, 86(1):95-100. 10.1002/(SICI)1097-0215(20000401)86:1<95::AID-IJC15>3.0.CO;2-G, 10728601.
44. Ravna AW, Sager G. Molecular modeling studies of ABC transporters involved in multidrug resistance. Mini Rev Med Chem 2009, 9(2):186-193. 10.2174/138955709787316065, 19200023.
45. Baker S, Favorov M, Dougan G. Searching for the elusive typhoid diagnostic. BMC Infect Dis 10:45.